GLP-1 medications are recommended in the ADA Standards of Care for those with cardiovascular disease, heart failure, and/or kidney disease to reduce the risk of adverse events due to these conditions
I'm thrilled to say that I've conquered my first goal, shedding an incredible 50 pounds! With a team of medical experts, were here to give you the best experience for personalized weight loss with comprehensive diagnostics and access to science-backed therapies and clinical guidance
+91 93560 92760 (cc: Anup Singh, Ira Sahay, Asmita Atre, Narasimha, Prachi Desai, Kaustubh Vaze, Ar
Reduction of metabolic syndrome: Researchers are exploring its role in creating a substantial relief and improvement of broader metabolic parameters (such as metabolic rate), including nutrient metabolism, lipid profiles, insulin resistance, glucose homeostasis, appetite control, and visceral adiposity
Endocrinology Advisor Conclusion The 2025 GLP-1 guidelines reflect a paradigm shift in the management of type 2 diabetes, emphasizing the multifaceted benefits of these agents
